Royal London Asset Management Ltd. raised its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 5.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 432,790 shares of the technology company's stock after acquiring an additional 21,011 shares during the quarter. Royal London Asset Management Ltd. owned approximately 0.19% of AMETEK worth $78,015,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. raised its stake in AMETEK by 62.6% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company's stock valued at $34,000 after purchasing an additional 77 shares during the last quarter. Versant Capital Management Inc raised its stake in AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock valued at $35,000 after purchasing an additional 187 shares during the last quarter. AdvisorNet Financial Inc raised its stake in AMETEK by 1,176.5% in the 4th quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock valued at $39,000 after purchasing an additional 200 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in AMETEK by 42.9% in the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company's stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new position in AMETEK in the 4th quarter valued at $43,000. 87.43% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on AME. BNP Paribas raised AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 target price for the company in a research note on Thursday, January 16th. StockNews.com raised AMETEK from a "hold" rating to a "buy" rating in a research report on Sunday, March 9th. Robert W. Baird cut their price objective on AMETEK from $200.00 to $197.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Bank of America raised AMETEK from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $195.00 to $225.00 in a research report on Monday, December 16th. Finally, Truist Financial raised their price objective on AMETEK from $221.00 to $222.00 and gave the stock a "buy" rating in a research report on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $204.67.
Check Out Our Latest Research Report on AMETEK
Insider Activity
In other news, Director Steven W. Kohlhagen sold 1,320 shares of AMETEK stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $189.41, for a total value of $250,021.20. Following the completion of the transaction, the director now owns 22,029 shares in the company, valued at approximately $4,172,512.89. This trade represents a 5.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.61% of the company's stock.
AMETEK Trading Down 0.8 %
AMETEK stock traded down $1.43 during midday trading on Friday, reaching $174.50. 1,422,601 shares of the stock traded hands, compared to its average volume of 1,162,164. The company has a 50-day simple moving average of $182.92 and a two-hundred day simple moving average of $180.53. AMETEK, Inc. has a 12-month low of $149.03 and a 12-month high of $198.33. The firm has a market cap of $40.26 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 2.73 and a beta of 1.14. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15.
AMETEK (NYSE:AME - Get Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.87 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.02. The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.82 billion. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. AMETEK's revenue for the quarter was up 1.8% on a year-over-year basis. During the same period last year, the business posted $1.68 EPS. Research analysts expect that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.
AMETEK Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Friday, March 14th. This is a boost from AMETEK's previous quarterly dividend of $0.28. AMETEK's dividend payout ratio (DPR) is presently 20.91%.
AMETEK announced that its board has authorized a stock repurchase program on Friday, February 7th that allows the company to buyback $1.25 billion in shares. This buyback authorization allows the technology company to reacquire up to 2.9% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued.
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report